Folkert W. Kamphuis Net Worth

What's Folkert Kamphuis's mailing address?

Folkert's mailing address filed with the SEC is 201 Mission St #2375, San Francisco, CA 94105, USA.

Insiders trading at Jaguar Health Inc

Over the last 10 years, insiders at Jaguar Health Inc have traded over $596,652 worth of Jaguar Health Inc stock and bought 670,772 units worth $1,311,594 . The most active insiders traders include Capital Partners, L.P.Sagar..., James J Bochnowski e Investments Ltd Burford Cap.... On average, Jaguar Health Inc executives and independent directors trade stock every 66 days with the average trade being worth of $27,901. The most recent stock trade was executed by Pravin R Chaturvedi on 17 May 2024, trading 871 units of JAGX stock currently worth $984.

What does Jaguar Health Inc do?

jaguar health, inc. is a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. our wholly-owned subsidiary, napo pharmaceuticals, inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. our mytesi® (crofelemer) product is approved by the u.s. fda for the symptomatic relief of noninfectious diarrhea in adults with hiv/aids on antiretroviral therapy. canalevia™ is our lead animal prescription drug candidate, intended for treatment of various forms of diarrhea in dogs. equilevia™ is jaguar’s non-prescription product for total gut health in equine athletes. to read our full social media policy, please visit https://jaguar.health/social-media-policy/

Jaguar Health Inc executives and stock owners

Jaguar Health Inc executives and other stock owners filed with the SEC include:

• Lisa Conte,
  President, Chief Executive Officer, Director
• Steven King,
  Executive Vice President - Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary
• Lisa A. Conte,
  Founder, CEO, Pres & Director
• Jonathan Wolin,
  Chief of Staff, General Counsel and Chief Compliance Officer
• Jonathan S. Wolin CPA, J.D., M.B.A.,
  Chief of Staff, Chief Compliance Officer & Gen. Counsel
• Dr. Steven R. King,
  Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
• James Bochnowski,
  Independent Chairman of the Board
• Jonathan Siegel,
  Independent Director
• Jiahao Qiu,
  Independent Director
• John Micek,
  Independent Director
• Gregory Divis,
  Independent Director
• Melissa Yeager,
  Senior Vice President - Regulatory Affairs & Quality Assurance
• Carol Lizak,
  Senior Vice President - Finance, Chief Accounting Officer
• Melissa A. Yeager J.D.,
  Sr. VP of Regulatory Affairs & Quality Assurance
• Ian H. Wendt M.B.A.,
  Chief Commercial Officer
• David Sesin,
  Chief Manufacturing Officer
• Dr. Karen Brunke Ph.D.,
  Exec. VP of Corp. & Bus. Devel.
• Peter Hodge,
  Sr. Director of Investor Relations, Bus. Devel. & Special Events
• Dr. Pravin R. Chaturvedi Ph.D.,
  Chair of Scientific Advisory Board & Acting Chief Scientific Officer
• Carol R. Lizak,
  Chief Financial Officer
• Roger J. Waltzman,
  Chief Scientific Officer
• Folkert W. Kamphuis,
  Director
• Philippe Brianceau,
  Chief Veterinary Officer
• Murray David Mac Naughtan,
  
• Zhi Yang,
  Director
• Ari Azhir,
  Director
• Karen Steil Wright,
  CFO and Treasurer
• Jeffery C. Johnson,
  
• Jonathan M Glaser,
  
• Bryan Bryan Ezralow 1994 Tr...,
  
• Investments Ltd Burford Cap...,
  
• Capital Partners, L.P.Sagar...,
  
• John A Kallassy,
  CFO, COO, Treasurer
• Management, Ltd.Kunlun Phar...,
  
• Michael Hauser,
  Chf Veterinarian, Clinical Ops
• Anula Jayasuriya,
  Director
• Pravin R Chaturvedi,
  Chief Scientific Officer